The PHQ-9 (Patient Health Questionnaire-9) is the most widely used depression screening instrument in US healthcare. Nine items, a 0–27 total score, and a validated severity-band structure make it the standard first-line screen for major depressive disorder — and the baseline measure in measurement-based care.
Quick answer: The PHQ-9 is a validated 9-item depression screener scored 0–27. Severity bands: 0–4 minimal, 5–9 mild, 10–14 moderate, 15–19 moderately severe, 20–27 severe. A score ≥10 is the positive-screen cutoff for major depressive disorder; any endorsement of item 9 triggers a suicide risk assessment.
Interactive Screening Calculator
PHQ-9 · GAD-7 · PHQ-2 — live scoring, no signup
PHQ-9 — Depression (9 items, 0–27)
1. Little interest or pleasure in doing things
2. Feeling down, depressed, or hopeless
3. Trouble falling or staying asleep, or sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself — or that you are a failure or have let yourself or your family down
7. Trouble concentrating on things
8. Moving or speaking so slowly others noticed, or being so fidgety/restless you have been moving around a lot more than usual
9. Thoughts that you would be better off dead, or of hurting yourself in some way
0/9 answered
GAD-7 — Anxiety (7 items, 0–21)
1. Little interest or pleasure in doing things
2. Feeling down, depressed, or hopeless
3. Trouble falling or staying asleep, or sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself — or that you are a failure or have let yourself or your family down
7. Trouble concentrating on things
0/7 answered
PHQ-9 Total
0/27Suggested ICD-10-CM if criteria met: F32.9/F33.9 · CPT 96127 billable when staff-administered & scored
GAD-7 Total
0/21Suggested ICD-10-CM if criteria met: F41.1 · CPT 96127 billable when staff-administered & scored
Educational tool — not a diagnosis. Results require interpretation by a qualified clinician. This screen does not replace the DSM-5-TR clinical interview.
This guide covers scoring, interpretation, and the clinical workflow around the PHQ-9.
Background: How the PHQ-9 Was Developed and Validated
The PHQ-9 was developed by Kroenke, Spitzer, and Williams and validated in a 2001 study published in the Journal of General Internal Medicine across more than 3,000 primary care and obstetrics-gynecology patients. It was derived from the full PRIME-MD diagnostic instrument — compressed from a 25-item clinician-administered interview into a 9-item self-report that takes about 3 minutes to complete.
At the ≥10 cutoff, the PHQ-9 achieves roughly 88% sensitivity and 88% specificity for major depressive disorder — accuracy comparable to structured clinician interviews. The instrument is free to use in clinical practice (Pfizer holds the copyright but permits free clinical use) and is available in 30+ validated translations.
The PHQ-9 is the depression counterpart to the GAD-7 anxiety screener — the two were developed by the same research group, share an identical 0–3 response scale, and are routinely administered together in measurement-based care.
The 9 Items
Each item asks about symptoms over the past 2 weeks. Response options are identical for all items:
| Response | Points |
|---|---|
| Not at all | 0 |
| Several days | 1 |
| More than half the days | 2 |
| Nearly every day | 3 |
| # | Item (abbreviated) |
|---|---|
| 1 | Little interest or pleasure in doing things |
| 2 | Feeling down, depressed, or hopeless |
| 3 | Trouble falling or staying asleep, or sleeping too much |
| 4 | Feeling tired or having little energy |
| 5 | Poor appetite or overeating |
| 6 | Feeling bad about yourself — or that you are a failure or have let yourself or your family down |
| 7 | Trouble concentrating on things, such as reading the newspaper or watching television |
| 8 | Moving or speaking so slowly that other people could have noticed; or the opposite — being so fidgety or restless that you have been moving around a lot more than usual |
| 9 | Thoughts that you would be better off dead, or of hurting yourself in some way |
Scoring
Sum all nine item scores. Total range: 0–27.
| Step | Calculation |
|---|---|
| Item scores | Each item: 0, 1, 2, or 3 |
| Total score | Sum of items 1–9 |
| Possible range | 0 (no symptoms) to 27 (all symptoms nearly every day) |
Severity Bands
The PHQ-9 total maps to five severity categories:
| Total score | Severity | Clinical meaning |
|---|---|---|
| 0–4 | Minimal depression | Few or no symptoms; routine care |
| 5–9 | Mild depression | Subthreshold or mild symptoms; watchful waiting, lifestyle measures, rescreen |
| 10–14 | Moderate depression | Positive screen for major depression; treatment recommended |
| 15–19 | Moderately severe depression | Active treatment indicated — therapy, medication, or both |
| 20–27 | Severe depression | Intensive treatment indicated; suicide risk assessment if item 9 endorsed |
The ≥10 Cutoff — What It Means
A PHQ-9 score of 10 or higher is the validated positive-screen threshold for major depressive disorder:
| Property | Value |
|---|---|
| Cutoff | ≥10 |
| Sensitivity | ~88% |
| Specificity | ~88% |
| Reference | Kroenke, Spitzer & Williams, J Gen Intern Med 2001 |
A score ≥10 does not diagnose depression — it identifies patients who need a clinical interview to establish DSM-5-TR criteria. Document both the screen result and the interview findings separately.
The PHQ-2 Pre-Screen
Items 1 and 2 alone form the PHQ-2, a 2-item ultra-brief screen:
| PHQ-2 score | Interpretation |
|---|---|
| 0–2 | Negative — depression unlikely; no further screening needed |
| ≥3 | Positive — administer full PHQ-9 |
The PHQ-2 exists for time-constrained settings (annual wellness visits, busy intake). It trades some accuracy for speed.
Item 9 — The Suicide Risk Flag
Item 9 asks about thoughts of being better off dead or hurting oneself. Any score ≥1 on item 9 requires action:
| Item 9 score | Required response |
|---|---|
| 0 | No action beyond routine documentation |
| ≥1 | Suicide risk assessment — direct clinical interview about ideation, plan, intent, means, and prior attempts; document the assessment and safety plan |
A positive item 9 is not itself a diagnosis — it is a mandatory trigger for further evaluation. Never ignore it.
Functional Impairment Question (Q10)
The PHQ-9 includes an optional 10th question (not scored): "If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?" — rated 0 (not difficult) to 3 (extremely difficult).
| Q10 score | Use |
|---|---|
| 0–1 | Symptoms may not meet functional-impairment criterion |
| 2–3 | Supports clinically significant impairment — relevant for DSM-5-TR criterion B |
Clinical Workflow
| Step | Action |
|---|---|
| 1. Administer | Patient completes PHQ-9 (paper, portal, or tablet) — takes ~3 minutes |
| 2. Score | Sum items; apply severity bands |
| 3. Check item 9 | If ≥1 → suicide risk assessment protocol |
| 4. Interpret | ≥10 → positive screen; 5–9 → monitor/rescreen; <5 → routine |
| 5. Diagnose | Positive screen → clinical interview for DSM-5-TR criteria |
| 6. Track | Repeat PHQ-9 every 2–4 weeks during active treatment to measure response |
Scoring Examples
| Scenario | Items pattern | Total | Severity |
|---|---|---|---|
| No symptoms | All 0s | 0 | Minimal |
| occasional low mood | Several 1s, one 2 | 5–9 | Mild |
| Moderate depression | Mix of 1s, 2s, a few 3s | 10–14 | Moderate |
| Severe depression | Mostly 2s and 3s, item 9 = 2 | 20–27 | Severe + suicide flag |
PHQ-9 vs. PHQ-2 vs. PHQ-15 — Choosing the Right Variant
| Variant | Items | Score range | Use case |
|---|---|---|---|
| PHQ-2 | 2 (anhedonia + depressed mood) | 0–6 | Ultra-brief pre-screen in time-constrained visits; ≥3 → full PHQ-9 |
| PHQ-9 | 9 | 0–27 | Standard depression screen + severity tracking |
| PHQ-15 | 15 somatic symptoms | 0–30 | Somatic symptom severity — not a depression measure despite the name |
The PHQ-15 screens for somatic symptom burden (it pairs with the somatic symptom disorder chapter of DSM-5-TR), while PHQ-2/PHQ-9 target depression. They are frequently confused in documentation — verify which instrument was actually administered before coding a screening claim.
Special Populations
| Population | Recommendation |
|---|---|
| Adolescents (11–17) | Use the PHQ-A (PHQ-9 Modified for Adolescents) — same scoring bands, adolescent wording; screen for suicidality given elevated adolescent risk |
| Perinatal patients | The EPDS (Edinburgh Postnatal Depression Scale) is preferred for pregnancy and postpartum; PHQ-9 is acceptable and widely used — item 9 wording needs clinical judgment around intrusive thoughts |
| Older adults | PHQ-9 performs well, but somatic items (sleep, fatigue, appetite) can be inflated by medical illness — interpret item trends, not just totals |
| Chronic medical illness | Same somatic-item caution; consider the PHQ-9's validity studies in chronic disease populations (diabetes, cardiovascular) which support continued use |
| Cultural/linguistic diversity | Use validated translations; scores are comparable across languages but cultural expression of distress varies — pair scores with clinical interview |
Payer Requirements for Depression Screening
| Program | Requirement | PHQ-9 role |
|---|---|---|
| Medicare Annual Wellness Visit | Depression screening is a required AWV element (HCPCS G0444) | PHQ-2 or PHQ-9 satisfies it |
| HEDIS | Depression screening and follow-up measures for behavioral health populations | Documented PHQ-9 with follow-up plan |
| Joint Commission / accreditation | Behavioral health screening documentation | Scored instruments with severity interpretation |
| CPT 96127 | Staff-administered test administration + scoring, billable | See billing section below |
Automated Scoring in Neuraline
Neuraline's AI Screening module ships with PHQ-9 pre-seeded — alongside GAD-7, Y-BOCS, BDI, HAM-D, MMSE, AUDIT, and CAGE — so scores compute automatically the moment a patient submits:
| Capability | How it works |
|---|---|
| Auto-scoring | Total score, severity band, and trend computed instantly — no hand tallying |
| Item-9 alert | Any item-9 endorsement flags the chart for suicide-risk follow-up |
| Portal administration | Assign PHQ-9 to patients; they complete it before the visit |
| Encounter administration | Administer and score during the visit |
| AI interpretation | Plain-language interpretation, clinical implications, and risk level |
| 3-click AI Charting | The score flows into the encounter note — draft, review, sign in three clicks |
The chart documents the instrument, score, severity, and interpretation automatically — audit-ready for CPT 96127 claims and HEDIS reporting.
Billing: CPT 96127
When staff administer and score the PHQ-9, the work is billable under CPT 96127 — psychological or neuropsychological test administration with scoring by a practice staff member under physician or qualified healthcare professional supervision, per hour of staff time:
| Rule | Detail |
|---|---|
| Who bills | The supervising physician or qualified healthcare professional |
| Time rule | Per hour of staff time; 16-minute minimum (one unit typically covers a screening session) |
| Frequency | Most payers allow one unit per patient per day |
| Same-day E/M | Generally billable alongside an E/M visit — document the screening separately |
| Documentation | Instrument name, administration date, raw score, severity interpretation, staff time, supervising provider |
| Typical reimbursement | Roughly $1–2 per unit (varies by payer and region) |
Medicare note: depression screening is a covered Annual Wellness Visit component (HCPCS G0444), and HEDIS measures require documented depression screening for behavioral health populations. The PHQ-9 satisfies both — document the score and interpretation either way.
Download the Free PHQ-9 PDF
Need a printable worksheet? Get the free PHQ-9 depression screening form — plus GAD-7, PCL-5, ASRS, C-SSRS, EPDS, and MDQ — in the Screening PDFs Library. All worksheets are free; scoring guides for each instrument are linked there too.
Frequently Asked Questions
Is the PHQ-9 a diagnostic test?
No. It is a screening and severity measure. A positive score indicates the need for clinical evaluation — it does not establish a diagnosis of major depressive disorder.
How often should PHQ-9 be repeated?
During active treatment, every 2–4 weeks is standard for monitoring response. A drop of ≥5 points is considered a clinically meaningful improvement.
Does PHQ-9 work for adolescents?
PHQ-9 is validated for ages 13+. For younger children, the PHQ-9 Modified for Adolescents (PHQ-A) is preferred.
Can PHQ-9 be used for billing?
Yes — depression screening measures support medical necessity for behavioral health services and are commonly required by payers for depression treatment authorization. Document the score, date, and clinical interpretation.
This guide summarizes PHQ-9 scoring for clinical reference. Always verify scoring against the official instrument and your organization's protocols.
Score PHQ-9 automatically in Neuraline — seeded screening instruments with severity bands and item-9 alert thresholds. Explore screening or book a demo.
